P-CMR[C] Program for Clinical Translation of Regenerative Medicine in Catalonia

Research, Stem cells & regenerative medicine, Research, Research services
Founded in 2019
L'Hospitalet de Llobregat, Catalonia
None

About P-CMR[C] Program for Clinical Translation of Regenerative Medicine in Catalonia

The Program for advancing the Clinical Translation of Regenerative Medicine of Catalonia, P-CMR[C], has been launched by the Center for Regenerative Medicine (CMR[B]) and the Biomedical Research Institute of Bellvitge (IDIBELL), at the behest of the Catalan Health Department of the Generalitat de Catalonia.P-CMR[C] was born with the aim to have a transformative impact on the way that basic, pre-clinical and clinical research in regenerative medicine are currently coordinated and eventually transferred to clinical practice in Catalonia.We are a comprehensive program where basic research, pre-clinical studies with new therapies and clinical trials with already existing therapies, coexist.MISSIONOur mission is to accelerate the implementation of strategies in Regenerative Medicine through the development of outstanding research projects addressed to solving medical needs that can be transferred to the clinical practice.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: Not available
  • Total Funding: None None
  • Last Funding: None None (None)
  • Funding Status: None

Technology Stack

P-CMR[C] Program for Clinical Translation of Regenerative Medicine in Catalonia actively uses None products in their tech stack.

Market Presence

Industries: Research, Stem cells & regenerative medicine, Research, Research services

Headquarters: L'Hospitalet de Llobregat, Catalonia